Department of Genetics, Stanford University School of Medicine, Stanford, CA.
Department of Genetics, Santa Clara Valley Medical Center, San Jose, CA.
Mol Genet Genomic Med. 2019 Jul;7(7):e00803. doi: 10.1002/mgg3.803. Epub 2019 Jun 12.
The views of people with genetic conditions are crucial to include in public dialogue around developing gene editing technologies. This qualitative study sought to characterize the attitudes of people with inherited retinal conditions (retinitis pigmentosa [RP] and Leber congenital amaurosis [LCA]) toward gene editing.
Individuals with RP (N = 9) and LCA (N = 8) participated in semi-structured qualitative interviews about their experience with and attitudes toward blindness, and their views about gene editing technology for somatic, germline, and enhancement applications.
Participants saw potential benefits from gene editing in general, but views about its use for retinal conditions varied and were influenced by personal perspectives on blindness. Those who felt more negatively toward blindness, particularly those with later onset blindness, were more supportive of gene editing for retinal conditions. Concerns about both germline and somatic editing included: the importance of informed consent; impacts of gene editing on social attitudes and barriers affecting blind people; and worries about "eliminating" blindness or other traits.
People with RP and LCA have diverse attitudes toward gene editing technology informed by their own lived experience with disability, and many have concerns about how the ways in which it is discussed and implemented might affect them.
将具有遗传条件的人的观点纳入围绕基因编辑技术开发的公共对话中至关重要。这项定性研究旨在描述遗传性视网膜疾病(色素性视网膜炎[RP]和莱伯先天性黑蒙[LCA])患者对基因编辑的态度。
9 名 RP 患者和 8 名 LCA 患者参加了关于他们失明经历和态度以及对体细胞、种系和增强应用基因编辑技术的看法的半结构式定性访谈。
参与者普遍认为基因编辑有潜在的好处,但对其用于视网膜疾病的看法因个人对失明的看法而异。那些对失明持更消极态度的人,特别是那些失明较晚的人,对基因编辑治疗视网膜疾病的支持度更高。对种系和体细胞编辑的担忧包括:知情同意的重要性;基因编辑对社会态度和影响盲人的障碍的影响;以及对“消除”失明或其他特征的担忧。
RP 和 LCA 患者对基因编辑技术的态度各不相同,这与其自身的残疾生活经历有关,许多人担心其讨论和实施方式可能会对他们产生影响。